ALNY - Alnylam Pharmaceuticals Non-GAAP EPS of -$1.62 misses by $0.28 revenue of $318.75M misses by $31.82M
2023-08-03 08:29:48 ET
- Alnylam Pharmaceuticals press release ( NASDAQ: ALNY ): Q2 Non-GAAP EPS of -$1.62 misses by $0.28 .
- Revenue of $318.75M (+41.8% Y/Y) misses by $31.82M .
For further details see:
Alnylam Pharmaceuticals Non-GAAP EPS of -$1.62 misses by $0.28, revenue of $318.75M misses by $31.82M